These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35126466)

  • 1. Comprehensive Analysis to Identify the Encoded Gens of Sodium Channels as a Prognostic Biomarker in Hepatocellular Carcinoma.
    Yan Y; He W; Chen Y; Li Q; Pan J; Yuan Y; Zeng W; Chen D; Xing W
    Front Genet; 2021; 12():802067. PubMed ID: 35126466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
    Zhou L; Chen G; Liu T; Liu X; Yang C; Jiang J
    Front Genet; 2022; 13():965805. PubMed ID: 36159990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma.
    Sun L; Yu S; Dong C; Wu Z; Huang H; Chen Z; Wu Z; Yin X
    Front Genet; 2022; 13():913398. PubMed ID: 35928441
    [No Abstract]   [Full Text] [Related]  

  • 5. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
    Wang Z; Chen S; Wang G; Li S; Qin X
    Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
    Xu H; Xiong C; Chen Y; Zhang C; Bai D
    Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cell divisioncycle-associated genes and their prognostic significance in hepatocellular carcinoma.
    Wang Z; Xu J; Zhang S; Chang L
    Int J Clin Exp Pathol; 2021; 14(2):151-169. PubMed ID: 33564348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Identification of Contradictory Role of ADAMTS5 in Hepatocellular Carcinoma.
    Zhu Z; Xu J; Wu X; Lin S; Li L; Ye W; Huang Z
    Technol Cancer Res Treat; 2021; 20():1533033820986826. PubMed ID: 33522433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma.
    Liu Y; Xu Y; Jiang M; Chen W; Zhu X
    J Cancer; 2021; 12(20):6254-6264. PubMed ID: 34539898
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive Analysis of the Value of SMYD Family Members in the Prognosis and Immune Infiltration of Malignant Digestive System Tumors.
    Liu D; Wang X; Shi E; Wang L; Nie M; Li L; Jiang Q; Kong P; Shi S; Wang C; Yan S; Qin Z; Zhao S
    Front Genet; 2021; 12():699910. PubMed ID: 34335697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
    Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
    World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
    Lü Y; Zhang J; Li L; Li S; Yang Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
    Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
    Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
    Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
    Oncologist; 2012; 17(1):13. PubMed ID: 22210086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
    Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C
    IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
    Wang Y; Huang Q; Deng T; Li BH; Ren XQ
    Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.